Echoing Sam Goldwyn, Nostrapharmus advises us to 'retaliate first!' Greater coherence across the industy, he predicts we will enable constructive agreement to serve the needs of pharma regulators, clinicians, and patients
What's stopping us?
As the regulatory grip tightens, Nostrapharmus predicted last month, you'll survive only by developing open and transparent collaboration between companies and regulators across the board of pharma activity. Or you could emulate Poor Robin: tuck your head under your wing and hope you're still there when winter's over... Better look at the practicalities!
Pharma needs to improve both its act and its performance. Everyone agrees on that. So what is stopping us? And what can we do to make it happen? We certainly need to be more pro‑active when working with regulators. It is a poor strategy to sit waiting for the worst to happen – and to feel bitterly satisfied when it does. But fighting individually to get your voice heard is no better. I don't think the regulators will be much interested in a Babel of different voices, concerns, issues and solutions! We need to offer them a clear industry position, or they will set the rules by default. Rules that will not be to our liking, nor necessarily contribute to public good.
To read the article in full, please click on the pdf link below:
About Pharma Magazine
Aimed at the international pharmaceutical and bio-pharmaceutical community, Pharma magazine covers every aspect of manufacturing from R&D to finished product. With a worldwide circulation of more than 40,000 individuals, it is the first truly global magazine for the pharma industry, bringing together the disciplines of discovery and development, the drug manufacturing process and the resultant business and management issues. For further information visit the Pharma website at www.pharma-mag.com